Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Debt / NOTE 1.000%11/1
-
Unit price / market price
-
$1.14
-
Total 13F principal
-
$603,301,410
-
Principal change
-
+$43,015,638
-
Total reported value
-
$689,201,293
-
Number of holders
-
59
-
Value change
-
+$48,576,904
-
Number of buys
-
18
-
Number of sells
-
23
Institutional Holders of ISIS PHARMACEUTICALS INC DEL - NOTE 1.000%11/1 as of Q3 2019
As of 30 Sep 2019 ISIS PHARMACEUTICALS INC DEL - NOTE 1.000%11/1 had 59 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $603,301,410 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included DeepCurrents Investment Group LLC, MACKAY SHIELDS LLC, STEELHEAD PARTNERS LLC, CALAMOS ADVISORS LLC, TENOR CAPITAL MANAGEMENT Co., L.P., WOLVERINE ASSET MANAGEMENT LLC, Verition Fund Management LLC, D. E. Shaw & Co., Inc., SILVERBACK ASSET MANAGEMENT LLC, and STATE STREET CORP.
This table shows 59 bond principal holders of the security as of 30 Sep 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.